Objectives: Beside having roles in energy homeostasis and endocrine modulation, adipose tissue (AT) is now considered a promising source of mesenchymal stromal cells (adipose-derived stromal cells or ASCs) for regenerative medicine. Despite numerous studies on cultured ASCs, native human ASCs are rarely investigated. Indeed, the phenotype of ASCs in their native state, their localization within AT and comparison with bone marrow-derived mesenchymal stromal cells (BM-MSCs) has been poorly investigated. Design: To address these issues, the stroma vascular fraction (SVF) of human AT was extracted and native cell subtypes were isolated by immunoselection to study their clonogenic potential in culture. Immunohistology on samples of human AT in combination with reconstruction of confocal sections were performed in order to localize ASCs. Results: Compared with BM-MNCs, all native ASCs were found in the CD34 þ cell fraction of the AT-SVF. Native ASCs expressed classical mesenchymal markers described for BM-MSCs. Interestingly, CD34 expression decreased during ASC cell culture and was negatively correlated with cell proliferation rate. Immunohistological analysis revealed that native ASCs exhibited specific morphological features with protrusions. They were found scattered in AT stroma and did not express in vivo pericytic markers such as NG2, CD140b or alpha-smooth muscle actin, which appeared during the culture process. Finally, ASCs spontaneous commitment to adipocytic lineage was enhanced in AT from obese humans. Conclusions: The use of complementary methodological approaches to study native human ASCs revealed their immunophenotype, their specific morphology, their location within AT and their stemness. Furthermore, our data strongly suggest that human ASCs participate in adipogenesis during AT development.
Introduction
Besides being involved in energy homeostasis, adipose tissue (AT) is an endocrine organ capable of secreting a large variety of regulatory proteins, including cytokines, chemokines and hormone-like factors such as leptin, adiponectin and resistin, referred to as adipokines. 1, 2 Such proteins participate in many other functions such as inflammation, immunity and reproduction. 3 Excessive AT development is thought to be the result of both adipocyte hypertrophy and apparent hyperplasia. [4] [5] [6] [7] [8] As adipocytes are terminally differentiated cells, and, as such, are considered incapable of division, 9,10 the apparent increase in adipocyte number is thought to originate from adipogenesis (the proliferation/ differentiation of adipocyte progenitor cells named preadipocytes). Thus, the expansion of adipose mass requires the presence of adipocyte precursor cells located in the stroma vascular fraction (SVF) of AT and the presence of which could also contribute to AT normal cell turnover during adulthood as recently suggested.
The search for the origin of adipocyte progenitors revealed that AT hosts a population of multipotent progenitors called adipose-derived stromal cells (ASCs). 12, 13 These progenitors can give rise to osteoblasts, chondrocytes and adipocytes. 12 They also participate in and/or support angiogenesis or vascular repair in ischemic limbs [14] [15] [16] and have immunomodulatory properties both in vitro and in vivo. 17, 18 A number of studies of the characterization of ASCs have revealed disparate and inconsistent parameters. Recurrent questions concern the nature of native ASCs, their tissue location, and their comparison with bone marrow-derived mesenchymal stromal cells (BM-MSCs). Reports, including our own, strongly suggest that native ASCs belong to an AT-SVF-derived CD34 þ cell population and are negative for haematopoietic (CD14, CD45) and endothelial markers (CD31). 14, 16, 19, 20 However, other groups propose the existence of two progenitor cell populations within AT: ASCs derived from CD34 þ cells and AT-MSCs derived from CD34 À cells. 18 Nevertheless, all reports agree with the classical BM-MSC surface immunophenotype of cultured ASCs:
À and CD14 À . [21] [22] [23] [24] [25] Another debated question concerns the origin of native ASCs. Indeed, although Crisan et al. 26 recently proposed that MSCs originate from a pericyte population lacking CD34 expression, Traktuev et al. 27 suggested a CD34 þ pericyte origin for
ASCs. In this context, this study aimed to clarify and better define the surface immunophenotype of both native and cultured human ASCs as compared with BM-MSCs, to evaluate in situ their morphology and to define their tissue localization within intact human AT samples. We show herein that native human ASCs (i) are CD34 positive (the expression of which is dramatically decreased in vitro when cells proliferate) (ii) display both stromal and perivascular positions but (iii) do not express in situ pericyte markers such as NG2 and CD140b, (iv) and exhibit in situ a peculiar cell morphology with long protrusions. Furthermore we propose that ASCs support AT growth, as their number is diminished and the expression of adipogenic markers increase as obesity and adipocyte hyperplasia progress.
Materials and methods
Adipose tissue sampling and SVF isolation Human subcutaneous AT samples were obtained from Caucasian women undergoing plastic surgery for lean (body mass index (BMI)o25 kg m À2 ) and obese class I (BMI 30-34.9 kg m
À2
) donors and undergoing bariatric surgery for classes II-III (BMIX35 kg m À2 ) obese subjects. The donors had a stable weight for at least 3 months before fat collection and their mean age was 43.7 ± 1.8 years, 44.4 ± 1.7 years and 43.4 ± 1.6 years for lean, class I and class II-III patients, respectively (some clinical characteristics of some class II-III obese donors are presented in Supplementary data 1). All research subjects provided their informed written consent before their surgery allowing the use of their tissue specimens for research purposes. The protocol followed the Declaration of Helsinki guidelines and was approved by the local ethics committee. The SVF and mature adipocytes were isolated from subcutaneous AT by collagenase digestion as previously described. 17, 28 As AT samples were derived from various surgical interventions (liposuction or dermolipectomy), ASC yield was compared depending on the surgical procedure. No statistically significant differences were found (1.3 Â 10 e5 ± 7.1 Â 10 e4 vs 1.2 Â 10 e5 ± 7.3 Â 10 e4 ASCs per g of AT for liposuction and dermolipectomy, respectively).
Adipocyte diameter determination
Once isolated, mature adipocytes were suspended in ECBM (Endothelial Cell Basal Medium, containing no growth factors)/0.5% BSA (Bovine Serum Albumin) (1V/10 V) and 5 ml of cell suspension were placed onto plastic slides. Three distinct calibrated fields were taken to measure manually adipocyte diameters with NIS software (Nikon, Champigny-sur-Marne, France). Fat cell-like shapes were labelled with the nucleus dye DAPI (4 0 ,6-diamidino-2-phenylindole). Among them 94 ± 1% were nucleated and identified as adipocytes (85 ± 7% and 99 ± 1%, for small (o60 mm) and large (4100 mm) adipocytes, respectively).
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Statistical analysis
Statistical analysis involved use of GraphPad (San Diego, CA, USA) and Statistica (Statsoft, Tulsa, OK, USA). Values are mean ± standard error of the mean of (n) separate experiments. Comparisons among different groups were analyzed by ANOVA, then post-hoc Dunnet multiple comparison tests or Mann-Whitney test for two groups. Differences were considered statistically significant at Po0.05.
Results
Phenotypic changes of cells from human adipose tissue SVF and BM-MNCs during the adhesion phase of primary culture Flow cytometry analysis of freshly harvested human AT SVF stained with anti-CD45 and anti-CD34 antibodies confirmed that native human SVF is a heterogeneous fraction made up of several cell populations, as was expected and in accordance with previous work, including our own 10, 13, 16 ( Figure 1a ). The cell populations in SVF included about 30% leukocytes, characterized as CD45 þ cells, and a cell population defined as CD34 þ /CD45 À , which represented about 40% of the cells from the SVF. Because adhesion to plastic is the most frequent way to select both ASCs and BM-MSCs, we used flow cytometry to investigate the evolution of CD34 and CD45 marker expression, together with that of standard MSC markers (CD73, CD13) in human SVF cells or BM-MNCs before and 2 days after adhesion to plastic. For the SVF, the adhesion phase was associated with an increased proportion of cells expressing CD13 and CD73 classic markers to identify BM-MSCs and a decreased proportion of cells positive for the leukocyte marker CD45 (Figure 1b) , with a concomitant increase in proportion of cells expressing CD34 (80%). Freshly harvested BM-MNCs contained less than 5% of CD34 þ cells, and in contrast to cells from the CD34 expression is downregulated during cell culture and is negatively correlated with cell expansion Because of conflicting results for CD34 expression in native ASCs, we hypothesized that changes in CD34 expression could be related to cell culture. Freshly harvested human AT-CD34 þ cells were cultured in 2 or 10% FCS for 8 days, and CD34 expression was analyzed using flow cytometry.
In parallel, the expression of standard MSCs and haematopoietic markers was studied before and after 8 days of culture. As expected, cell yield was greater than fivefold higher in 10 than 2% FCS medium (Figure 2a ). Whatever the medium used (2 or 10% FCS) and in agreement with our previous observation, the proportion of CD34 Native human adipose tissue-derived CD34 þ cells contain CFU-F activity, adipogenic and osteogenic potentials CFU-F activity was assessed in freshly harvested CD34 þ and CD34 À cell populations from AT. CFU-F activity was restricted to the CD34 þ cell population (Figures 3a and b) .
After inducing adipogenic differentiation in confluent cells, we detected lipid accumulation by Oil-red O staining and triglyceride content (data not shown) in the CD34 þ cell fraction (Figures 3c and d) . At 3 weeks after the induction of osteogenic differentiation, matrix mineralization was observed in the CD34 þ cell fraction (Figures 3e and   f ). Under the same conditions, the CD34 À cell fraction from AT revealed neither osteogenesis nor adipogenesis (Figures 3c-f ).
Phenotypic characterization of native and cultured ASCs
According to the results shown above, we assumed that native ASCs were in the CD34 þ CD45 À cell fraction of the AT derived-SVF. We studied the expression of various membrane markers in the freshly harvested cell population before culture and after 8 days of culture. Cell culture led to a clear phenotype homogenization (Table 1 and Supplementary data 6 and 7), with no marked phenotype evolution between the first and second cell passage (data not shown). More than 95% of cultured ASCs expressed a large variety of MSCs markers (CD9, CD10, CD13, CD49e, CD73, CD90 and CD166) but no haematopoietic markers (CD3, CD11c, CD14, CD15, CD16, CD18 and CD41) ( Table 1 ).
In situ localization of native ASCs
To examine the spatial organization of ASCs within human AT, we investigated the vascular network in intact human AT by anti-lectin or -CD31 antibody staining, which produced identical patterns (data not shown). Native ASCs were localized with anti-CD34 antibodies and were distinguished from leukocytes and endothelial cells with the use of anti-CD45 and anti-lectin antibodies, respectively. Adipocytes were detected by phase contrast imaging. We found human AT capillaries, characterized by aligned cells positive for lectin or CD34, distributed among adipocytes (Figure 4a ). Interestingly, CD34 staining revealed CD34 þ cells mainly located in AT stroma and sometimes near capillaries (Figure 4a ). To discriminate ASCs from AT capillary endothelial cells, double staining with anti-lectin and -CD34 antibodies was performed (Figure 4b) . A large proportion of ASCs were visualized as scattered throughout AT stroma, some were found close to capillaries and seldom adhering to AT capillaries (Figures 4a and b) . To verify that ACS stromal location was indeed devoid of capillaries and because of AT intrinsic structure, that is the presence of large mature adipocytes sometimes reaching diameters of 100-150 mm, reconstruction of confocal sections on 25-mm thickness from human AT sample was performed. Human AT was labelled with anti lectin and CD34. The optical sectioning capability of confocal imaging confirmed that human native ASCs located in the stroma of AT were not close to capillaries. Moreover, in their native microenvironment human ASCs exhibited a branched morphology with several lateral protrusions, which could reach a length of 80 mm (Figure 4c and Supplementary data movie). Furthermore, some cell branches, already revealed in AT-derived CD34 þ and CD34 À cells were cultured under osteogenic conditions for 3 weeks; alizarin-red staining for matrix mineralization (e) and quantification (f) (n ¼ 6, *Po0.001).
Native ACSs are CD34 þ and scattered in adipose stroma M Maumus et al differentiation potentials of ASCs was studied. The number of ASCs by flow-cytometry analyses was examined and the expression of several genes involved in adipogenic and osteogenic programs in freshly harvested ASCs from donors exhibiting class I to class III obesity by real-time PCR analyses was investigated. Subcutaneous AT from class I obese individuals exhibited more ASCs than lean individuals (1.1 Â 10 e5 ± 8.7 Â 10 e3 vs 1.6 Â 10 e5 ± 1.4 Â 10 e4 ASCs per g of AT in lean vs class I obese donors, respectively, Po0.05, n ¼ 50 and 38, respectively) and class II-III obese individuals (1.5-fold decrease, n ¼ 59, Po0.05, Figure 6a ). The lower number of ASCs in class II-III obese subjects was accompanied by a reduced mean diameter of subcutaneous mature adipocytes (Figure 6b ), but with higher transcript levels of mRNA encoding for the adipocyte markers LPL and GPDH as compared with subjects with class I obesity (Figures 6c and  d) . To note, no expression of osteogenic genes such as Runx2 and osteocalcin were detected in native ASCs and no change in their expression was found whatever the degree of obesity (data not shown).
Discussion
In this study, we show that native ASCs are contained in the CD34 þ cell population of AT and that the expression of CD34 marker is negatively correlated with cell expansion in vitro. In intact human AT, ASCs were found scattered in AT stroma, occasionally close to capillaries but interestingly without expressing pericytic markers in situ, as previously reported. Excessive AT development, as seen in humans with severe obesity (class II-III), was associated with a lower ASC number and smaller mean adipocyte diameter together with a marked increase in the expression of adipogenic molecular markers (LPL and GPDH) in native ASCs from subcutaneous AT suggesting activation of an adipogenic differentiation program presumably to support the adipocyte hyperplasia seen in severe forms of obesity. CD34 belongs to the family of single-pass transmembrane sialomucin proteins that contains three members: CD34, podocalyxin and endoglycan. 29 For 25 years, CD34 has been widely used to identify and isolate haematopoietic stem and progenitor cells. 30 More recently, CD34 has been used to help identify other tissue-specific stem or progenitor cells such as satellite muscle cells and epidermal precursors. 29 It is also widely used as a marker of vascular endothelial cells, [31] [32] [33] endothelial progenitor cells, 34 fibrocytes, 35 human decidual stromal cells, 36 satellite cells 37 and keratocytes. 38 Culture-expanded BM-MSCs are generally considered negative for CD34 marker, but the expression of CD34 in freshly harvested MSCs is still debated. Indeed, 
0.9±0. Conventional techniques used to visualize tissue structure generally involve excision and sectioning of the tissue; however, such techniques do not facilitate direct visualization of the complex cellular interactions taking place in 3-D. Hence, to better characterize native ASCs, we used immunohistochemistry of intact human AT analyzed by fluorescent microscopy and also confocal microscopy. This method preserves the 3-D structure and allowed us to finely investigate ASC distribution within the complex 3-D architecture of human AT (thickness of 25 mm). We found human ASCs to exhibit specific morphological features with very long protrusions allowing them to form networks surrounding mature adipocytes. Native human ASCs were found scattered within AT. Indeed, human ASCs were largely located in the stroma of human subcutaneous AT, although some were found near the capillary network. However, they rarely exhibited a pericytic position. Interestingly, similar results were found in mouse subcutaneous AT, with mouse ASCs found in the deep layers of AT as well as near microvessels. 45 The 54, 55 Similar to Oct4 and Nanog, the catalytic subunit of human telomerase (hTERT) is described more as a stem cell marker for ESCs than for adult stem/progenitor cells. Telomerase is expressed in cultured ASCs. [56] [57] [58] [59] We report for the first time that hTERT is not detected in human native ASCs. Finally, we studied the effects of AT microenvironment changes on ASC adipogenic or osteogenic commitment. Excessive AT development, as found in humans with obesity, was associated with increased expression of adipogenic differentiation genes and no change in expression of osteogenic differentiation genes. The excessive development of AT results from both hypertrophy of pre-existing adipocytes and adipocyte hyperplasia due to the formation of new adipocytes. 5, 10 Because adipocytes are terminally differentiated cells and therefore considered incapable of division. 9, 10 The apparent increase in adipocyte number is thought to originate from adipogenesis and/or the proliferation or differentiation of adipocyte progenitor cells (preadipocytes). We have recently demonstrated a correlation between excessive AT development in humans and increased number of mature adipocytes, together with increased progenitor-cell proliferation. 60 Our current results indicate that the number of native ASCs in subcutaneous AT was lower in subjects with class II-III obesity who also exhibited lower mean adipocyte diameter than class I obese donors. Our unpublished observations indicate no association between the number of ASCs and the duration of obesity. Furthermore, the mRNA levels of adipogenic markers LPL and GPDH were markedly higher in native ASCs from donors with class II or III obesity than in those with class I obesity. These findings suggest that ASCs may support the adipocyte hyperplasia that occurs in severe obesity as shown by the lower mean adipocyte diameter compared with class I obese patients.
In conclusion, our use of complementary methodological approaches to study native human ASCs from subcutaneous AT revealed data regarding their immunophenotype, their location within human AT, their 3-D morphology and their stemness. Furthermore, our data strongly suggest that human ASCs participate in adipogenesis, which occurs during excessive AT development. Further studies are needed to better understand how changes in AT microenvironment could participate in ASC commitment and therefore help elucidate the optimal conditions for developing viable and safe tools for tissue engineering.
